Clinical Trial Update: The Effect of Intranasal Administration of Oxytocin on Empathic Abilities. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating whether intranasal oxytocin improves empathic abilities in people with schizophrenia; the trial status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Oxytocin (Oxytocin)

Snippet

Sponsor: Shalvata Mental Health Center | Conditions: Schizophrenia | Phase 2 | Status: UNKNOWN